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Glucose profiles in healthy volonteers assessed by CGMS (Guardian®) 
 
 
Author/Address of institution 
Krummenacher Irène, Fischli Stefan, and Henzen Christoph 
Division of Endocrinology and Diabetology, Luzerner Kantonsspital, CH-6000 Luzern 16 
 
 
Background/Introduction 
Continuous measuring of subcutaneous glucose levels is feasible with the Guardian® REAL-Time 
CGMS, providing additional information about glucose fluctuations in diabetic patients. However, 
only few data are available describing normal glucose fluctuations, i.e. continuous glucose profiles 
in healthy people, and there are no data published yet for caucasians.      
 
Methods 
Inclusion of healthy volonteers, 18 to 50 years old, with normal BMI and normal oGTT, who had the 
instruction and placement of the Medtronic® Guardian® REAL-Time CGMS for 48 hours, and who 
were leading a protocol of carbohydrate intake and physical activity.  
 
Results 
A total of 15 probands (7 male/8 female) were included: mean age (SD) 39.8 (9.3) years, mean 
BMI 21.3 (1.9), mean daily carbohydrate intake 251 (98) g with a minimal intake of 100 g and a 
maximum intake of 510 g, and a median daily physical activity of 9.5 min (minimum 0 min, 
maximum 110 min). There were no problems with the Guardian® REAL-Time CGMS, and 
complete data set were created for all probands with a total of 10.329 glucose readings. The mean 
24h glucose concentration was 5.31 (0.87) mmol/l, the minimal glucose level was 3.44 mmol/l, the 
maximum glucose level 7.55 mmol/l. Glucose readings of the CGMS and the capillary blood 
glucose levels (for calibration) correlated well (R=0.22, p=0.011).   
 
Conclusion 
In healthy volonteers there is a very thight control of glucose fluctutations as assessed with the  
Guardian® REAL-Time CGMS. Although, there was a great difference in carbohydrate intake and 
physical activity, glucose concentrations almost always remained in the normoglycemic range.  
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Red head, Horner`s syndrome and syncope – where is the link? 
 
 
Author/Address of institution 
R. Locher, I. Krull, M. Brändle 
Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St. Gallen 
 
 
Background/Introduction 
While thyroid nodular goiter is a common condition, it rarely causes local complications such as 
superior cava syndrome, carotid sinus syndrome or Horner`s syndrome. We report on a patient 
with an uncommon cause of a cystic thyroid mass leading to these compressive symptoms. 
 
Case Report 
A 68-year-old man presented at the emergency room with a syncope. The clinical examination 
revealed redness of the head, right sided Horner`s syndrome and a 10x10 cm large, indurated, 
fixed mass at the right thyroid lobe without local redness or tenderness. CRP and blood leucocytes 
were grossly elevated, indicating systemic inflammation. Computed tomography of head and neck 
revealed a spacious cystic nodule of the right thyroid lobe. A purulent appearing fluid was drained 
by fine needle aspiration and the cytologic and microbiological workup included a bacterial or 
tuberculous abscess, malignant tumor including anaplastic thyroid carcinoma and metastasis as 
differential diagnoses. Computed tomography of the chest showed multiple pulmonary tumorous 
lesions equivocal for lung cancer. Bronchoscopy-guided fine needle aspiration cytology yielded a 
non-small-cell lung carcinoma, which was compatible with the results obtained from the thyroid 
nodule. Palliative drainage of the thyroid mass was attempted with partial resolution of the 
compressive symptoms. During follow-up the patient died from septic shock. Autopsy confirmed a 
non-small-cell carcinoma of the lung with multiple lymph node metastases infiltrating both thyroid 
lobes. The red head reflecting a positive Pemberton sign, Horner`s syndrome (miosis, ptosis) and 
syncope were explained by thrombosis of the vena cava superior, tumor compression of the 
sympathetic nerve system and carotid sinus. 
 
Conclusion 
Local tumor infiltration or metastatic involvement of the thyroid gland by a malignant tumor is a 
rare, but important differential diagnosis of thyroid nodules. Although a cystic thyroid lesion is not 
per se suspicious for malignancy, the distinct symptoms caused by local compression led to the 
likely diagnosis of a malignant disease. 
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Familial non-autoimmune hyperthyroidism due to an activating TSH receptor 
mutation 
 
 
Author/Address of institution 
R. Locher, S. Bilz, M. Brändle 
Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St. Gallen 
 
 
Background/Introduction 
The most frequent causes for hyperthyroidism are Graves’ disease and thyroid nodules with 
autonomous function which account for more than 90% of thyrotoxicosis. 
 
Case Report 
A 63-year-old man with a history of hyperthyroidism first described in childhood was referred. 
Despite negative TSH-receptor antibodies and absence of thyroid eye disease hyperthyroidism 
had been supposed to be secondary to Graves’ disease. He had never attained an euthyroid state 
despite thionamide therapy. Clinical examination and thyroid ultrasound showed a large 
multinodular goiter (~ 60 ml), and subclinical hyperthyroidism persisted despite daily therapy with 
7.5 mg carbimazole.  
The further diagnostic work-up revealed cardiomyopathy with atrial fibrillation and decreased left 
ventricular ejection fraction and severe osteopenia, both presumably due to long-standing 
hyperthyroidism. Remarkably, his family history was positive for multinodular goiter and 
hyperthyroidism in both his father and grandfather and his son and daughter, suggesting 
autosomal-dominant, familial non-autoimmune hyperthyroidism. Indeed, an activating mutation 
(Gly431Ser) in the first membrane spanning domain of the TSH-receptor (TSHR) was found in the 
patient’s son, confirming the diagnosis. Whereas both children underwent thyroid ablation with 
131J, our patient has denied thyroidectomy or treatment with radioiodine. 
 
Conclusion 
TSHR germline mutations occur as activating mutations in familial non-autoimmune 
hyperthyroidism (FNAH) or sporadic non-autoimmune hyperthyroidism (SNAH). The diagnosis of 
FNAH should be considered in cases with a positive family history, early onset of hyperthyroidism, 
goiter, absence of clinical stigmata of autoimmunity and recurrent hyperthyroidism or resistance to 
medical therapy, whereas SNAH is characterized by absence of a family history. Although those 
mutations are rare, their prevalence may be underestimated and should be considered as an 
important differential diagnosis of hyperthyroidism, particular in patients with any of the described 
stigmata. The persistent excess of thyroid hormones leads to several organ damages including 
cardiopathy and osteoporosis. Thus, optimal management of hyperthyroidism due to activating 
TSHR gene mutation includes total thyroidectomy alone or in combination with radioiodine to 
destroy all thyroid tissue and prevent recurrent disease. 
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Association between circulating cytokine levels, diabetes and insulin 
resistance in a population-based sample (CoLaus study). 
 
 
Author/Address of institution 
Pedro Marques-Vidal 1; François Bastardot 2; Roland von Känel 3; Fred Paccaud 1; Martin Preisig  
4; Gérard Waeber 2 and Peter Vollenweider 2 
1 Institute of Social and Preventive Medicine (IUMSP), CHUV and Faculty of biology and medicine, 
Lausanne; 2 Department of Medicine, Internal Medicine, CHUV and Faculty of biology and 
medicine, Lausanne; 3 Division of Psychosomatic Medicine, Bern University Hospital Inselspital, 
and University of Bern; 4 Department of Psychiatry, CHUV, Lausanne, Switzerland 
 
 
Background/Introduction 
The objective of this study was to assess the associations between diabetes, insulin resistance 
(assessed by HOMA), metabolic syndrome and cytokine (interleukin-1beta - IL-1β; interleukin-6 – 
IL-6 and tumor necrosis factor-α – TNF-α) and high sensitivity C-reactive protein (hs-CRP) in a 
healthy Caucasian population. 
 
Methods 
Population sample of 2884 men and 3201 women aged 35 to 75. CRP was assessed by 
immunoassay; the other cytokines were assessed by multiplexed particle-based flow cytometric 
assay. An oral glucose tolerance test was performed in a subgroup of 532 randomly selected 
participants to screen for impaired glucose tolerance (IGT). 
 
Results 
IL-6, TNF-α and hs-CRP were significantly and positively correlated with fasting plasma glucose, 
insulin and HOMA-IR. Participants with diabetes had higher IL-6, TNF-α and hs-CRP levels than 
non-diabetics; after multivariate adjustment this difference persisted for hs-CRP only. Participants 
with metabolic syndrome had higher IL-6, TNF-α and hs-CRP levels and these differences 
persisted after multivariate adjustment. Participants in the highest quartile of HOMA-IR had higher 
IL-6, TNF-α and hs-CRP levels, but these differences persisted for TNF-α and hs-CRP only after 
multivariate adjustment. No association was found between IL-1β levels and all diabetes and 
insulin resistance markers studied. Finally, participants with IGT had higher hs-CRP levels than 
participants with a normal OGTT, but this difference disappeared after adjusting on body mass 
index. 
 
Conclusion 
Subjects with diabetes, metabolic syndrome and increased insulin resistance present with higher 
levels of IL6, TNF-α and hs-CRP, while no association was found with IL-1β. The increased 
inflammatory state of subjects with IGT appears to be mediated by BMI. 
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